The association of PTEN loss on outcome in patients with early high-risk prostate cancer (CaP) treated with adjuvant docetaxel following radical prostatectomy (RP).
Year: 2011
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: D. Keizman, Z. Zhang, V. J. Sinibaldi, A. DeMarzo, B. Gurel, T. Lotan, J. Hicks, E. Rosenbaum, E. S. Antonarakis, J. J. Kim, M. A. Carducci, M. A. Eisenberger
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2560804368